Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “OligoProgressive Metastatic Disease”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Not applicableActive Not RecruitingNCT04624828
What this trial is testing

Immune Response Evaluation in Oligorecurrent and Oligoprogressive Prostate Cancer Patients Treated With SBRT

Who this might be right for
Oligorecurrent and Oligoprogressive Prostate Cancer Patients
Istituto Clinico Humanitas 40
Testing effectiveness (Phase 2)Looking for participantsNCT06927635
What this trial is testing

Stereotactic Body Radiotherapy or Standard of Care for Prostate Oligoprogressive Cancer

Who this might be right for
Castrate Resistance Prostate CancerOligoProgressive Metastatic Disease
University Health Network, Toronto 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT03808662
What this trial is testing

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

Who this might be right for
TNBC - Triple-Negative Breast CancerTriple Negative Breast CancerNSCLC+4 more
Memorial Sloan Kettering Cancer Center 107
Testing effectiveness (Phase 2)Active Not RecruitingNCT04405401
What this trial is testing

Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer

Who this might be right for
Lung Cancer Metastatic
Centre hospitalier de l'Université de Montréal (CHUM) 68
Not applicableLooking for participantsNCT06925984
What this trial is testing

Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast)

Who this might be right for
OligoProgressive Metastatic Disease
Jules Bordet Institute 48
Not applicableNot Yet RecruitingNCT06489821
What this trial is testing

STereotactic Body Radiotherapy (SBRT) for Oligoprogressive Breast Cancer

Who this might be right for
Metastatic Breast CancerOligoprogression
Juravinski Cancer Center 36
Large-scale testing (Phase 3)Active Not RecruitingNCT07076693
What this trial is testing

Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）

Who this might be right for
OligoProgressive Metastatic DiseaseNon-Small Cell Lung Cancer
Shanghai Chest Hospital 97
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06813664
What this trial is testing

CtDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI)

Who this might be right for
Metastatic NSCLC - Non-Small Cell Lung CancerOligoProgressive Metastatic Disease
University Health Network, Toronto 60
Large-scale testing (Phase 3)Looking for participantsNCT06686771
What this trial is testing

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Canadian Cancer Trials Group 320
Not applicableLooking for participantsNCT07112170
What this trial is testing

Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Melanoma

Who this might be right for
Metastatic MelanomaOligoProgressive Metastatic Disease
University Health Network, Toronto 52
Not applicableLooking for participantsNCT07691697
What this trial is testing

PSMA PET-Staged Comprehensive Progression-Directed Radiotherapy for Limited Progression in Prostate Cancer

Who this might be right for
Oligoprogressive Prostate CancerMetastatic Prostate Cancer
Affidea Nu-med Center of Oncological DIagnostics and Therapy 1,000
Early research (Phase 1)Looking for participantsNCT07619599
What this trial is testing

A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainOligoprogressive Lung Non-Small Cell Carcinoma+1 more
City of Hope Medical Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT04299646
What this trial is testing

A Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases

Who this might be right for
Metastatic Renal Cell CarcinomaRadiotherapy
Centre Francois Baclesse 77
Testing effectiveness (Phase 2)Active Not RecruitingNCT04070209
What this trial is testing

Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)

Who this might be right for
Metastatic Prostate CancerCastration-resistant Prostate Cancer
Sir Mortimer B. Davis - Jewish General Hospital 66
Not applicableNot Yet RecruitingNCT06882499
What this trial is testing

Stereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II

Who this might be right for
Breast Cancer, MetastaticMetastatic Breast Cancer
Peter MacCallum Cancer Centre, Australia 74
Not applicableActive Not RecruitingNCT06055881
What this trial is testing

Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy

Who this might be right for
Breast CarcinomaAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast Cancer
Mayo Clinic 45
Testing effectiveness (Phase 2)Looking for participantsNCT07038304
What this trial is testing

The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer (Adenocarcinoma)OligoProgressive Metastatic DiseaseCastration Resistant Metastatic Prostate Cancer+1 more
University Medical Center Groningen 35
Not applicableLooking for participantsNCT05784428
What this trial is testing

Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression

Who this might be right for
Oligometastatic DiseaseOligoprogressionToxicity Due to Radiotherapy+1 more
Robert Olson 598
Large-scale testing (Phase 3)Looking for participantsNCT06523673
What this trial is testing

Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Non-Small Cell Lung CancerNSCLC Stage IVOligoProgressive Metastatic Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine 104
Testing effectiveness (Phase 2)Looking for participantsNCT06260033
What this trial is testing

Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor-Positive Breast CarcinomaMetastatic Breast Carcinoma
City of Hope Medical Center 18
Next Page